💊 Is AI discovery and development a real thing? It's further along than you may have realized.

Substack is a platform for independent writers and journalists to publish and monetize their content. Through newsletters, articles, and podcasts, Substack offers insights into a wide range of topics such as politics, technology, culture, and personal development. Readers can subscribe to their favorite writers and receive regular updates, analysis, and commentary on the issues that matter to them. Additionally, Substack provides tools and resources for writers to grow their audience, engage with their readers, and monetize their content effectively.

Substack

Insilico Medicine is a biotech company that uses AI in drug discovery and development. They are developing drugs for various diseases and have a focus on drug repurposing. Insilico Medicine uses AI platforms like PandaOmics, Chemistry42, and inClinico. They have collaborated with companies like GSK, Pfizer, and Novo Nordisk. The company has a high valuation and has raised significant funding. They also have an Intelligent Robotics Drug Discovery Laboratory. The use of AI in drug discovery offers advantages in efficiency and cost reduction. The study published by Insilico Medicine in Nature Biotechnology is significant in demonstrating the translation of AI-predicted findings into clinical trials. The Vice President of Business Development at Insilico Medicine is Keith Mikule.

The Biotech AI Revolution is Nearly Here in 2024